Is the Options Market Predicting a Spike in AMN Healthcare Services Stock?
The options market suggests a potential significant price movement for AMN Healthcare Services (AMN) stock, highlighted by high implied volatility in its Dec 18, 2026 $05.00 Call option. This often indicates investor expectations of a large move or an upcoming event. Analysts currently rate AMN as a Zacks Rank #3 (Hold), with recent upward revisions to earnings estimates, further fueling interest in the stock's future performance.
Here's Why AMN Healthcare Services (AMN) is a Strong Momentum Stock
AMN Healthcare Services (AMN) is identified as a strong momentum stock based on Zacks Style Scores. Despite holding a Zacks Rank #3 (Hold), it boasts a Momentum Style Score of A and a VGM Score of A, alongside significant share price growth and upward earnings estimate revisions from analysts. The article highlights how Zacks Style Scores combine with the Zacks Rank to identify stocks with the best market outperformance potential.
Does Fitch’s Stable Outlook on AMN (AMN) Hint at Durable Margins or Just Temporary Clarity?
Fitch has affirmed AMN Healthcare Services' (AMN) issuer ratings and revised its credit outlook to Stable, signaling clearer visibility on revenue and margin stabilization despite soft Q2 guidance. While this supports the company's business resilience, investors should remain aware of ongoing core demand risks and potential margin squeeze from wage inflation. The article discusses how Fitch's stable outlook provides some clarity but doesn't erase concerns about persistent challenges like tighter hospital budgets and tech-driven competition.
AMN Healthcare Services, Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:AMN) 2026-05-14
AMN Healthcare Services, Inc. (NYSE:AMN) has released its Q1 2026 earnings call presentation, reporting an EPS of $2.10, beating estimates by $0.48, and revenue of $1.38 billion, exceeding expectations by $144.79 million with a 99.90% year-over-year increase. The presentation accompanies their earnings call from May 14, 2026.
The Top 5 Analyst Questions From AMN Healthcare Services’s Q1 Earnings Call
AMN Healthcare Services reported a strong Q1 2026, driven by rapid scaling for labor disruption events and improved performance in Nurse and Allied Staffing divisions. Revenue and adjusted EPS significantly beat analyst estimates, though Q2 revenue guidance is slightly below expectations. Analysts focused on post-pandemic normalization of contract labor, the impact of disruption events on client relationships, distinctions between rapid response and labor disruption revenues, long-term EBITDA growth strategies, and Q2 gross margin guidance.
UBS Remains a Hold on AMN Healthcare Services (AMN)
UBS analyst A.J. Rice maintained a Hold rating on AMN Healthcare Services (AMN) with a price target of $32.00, while other analysts provided mixed ratings. The company recently reported Q1 revenue of $1.38 billion and a net profit of $62.17 million.
Eric Palmer Joins AMN Healthcare Board of Directors
AMN Healthcare, a leader in healthcare talent solutions, announced the election of Eric Palmer to its Board of Directors, effective May 1, 2026. Palmer brings over 25 years of leadership experience in healthcare services, benefits, and insurance, previously serving as CEO of Evernorth Health Services and CFO of Cigna. His appointment is expected to bolster AMN's governance and long-term growth strategy due to his expertise in scaling organizations and navigating dynamic markets.
AMN Maintained by UBS -- Price Target Raised to $32.00
UBS analyst A.J. Rice has maintained a Neutral rating for AMN Healthcare Services (AMN) while significantly raising its price target to $32.00 from $19.50, reflecting increased confidence in the company's performance. GuruFocus data indicates AMN is currently undervalued by 17.3% with a GF Value™ of $35.66 and boasts a solid GF Score™ of 73/100, though its growth rank is low at 2/10. Investors are advised to consider potential opportunities with caution.
Executive who led $200B Evernorth unit joins AMN Healthcare board
AMN Healthcare has appointed Eric Palmer, former CEO of Evernorth Health Services and CFO of Cigna, to its Board of Directors, effective May 1, 2026. Palmer's extensive experience in healthcare services, benefits, and insurance, including leading Evernorth to over $200 billion in revenue and orchestrating Cigna's acquisition of Express Scripts, is expected to enhance AMN's governance and support its long-term growth strategy. He currently also serves on the board of LifeStance Health and other institutions.
AMN Healthcare adds Eric Palmer to board of directors
AMN Healthcare has appointed Eric Palmer to its board of directors, effective May 1, 2026. Palmer, who brings over 25 years of healthcare experience, including leadership roles at Evernorth Health Services and Cigna, joins as the company navigates a financial turnaround, with its stock up 87% year-to-date. Analysts expect AMN Healthcare to be profitable this year after a previous loss, supported by strong Q1 2026 financial results that exceeded expectations.
Press Release: Eric Palmer Joins AMN Healthcare Board of Directors
AMN Healthcare has announced that Eric Palmer, former Executive Vice President and Chief Financial Officer of Voya Financial, has been appointed to its Board of Directors, effective May 12, 2026. Palmer's extensive experience in finance and corporate strategy, particularly within the healthcare services and financial sectors, is expected to be a valuable asset to AMN Healthcare as it continues its growth and market leadership. He currently serves on the boards of publicly traded companies Oscar Health and Global Medical Response.
Eric Palmer Joins AMN Healthcare Board of Directors
AMN Healthcare Services Inc. has announced the election of Eric Palmer to its Board of Directors, effective May 1, 2026. Palmer, a seasoned healthcare executive with over 25 years of experience, previously served as CEO of Evernorth Health Services and CFO of Cigna, bringing valuable leadership in large-scale operations and strategic growth to the board. His appointment is expected to strengthen AMN's governance and support its long-term growth strategy in providing healthcare talent solutions.
Eric Palmer Joins AMN Healthcare Board of Directors
AMN Healthcare announced the election of Eric Palmer to its Board of Directors, effective May 1, 2026. Palmer brings over 25 years of leadership experience in healthcare services, benefits, and insurance, including leading Evernorth Health Services to over $200 billion in revenue and playing a key role in Cigna's acquisition of Express Scripts. His appointment is expected to strengthen AMN's governance and support its long-term growth strategy.
Eric Palmer Joins AMN Healthcare Board of Directors
AMN Healthcare announced the election of Eric Palmer to its Board of Directors, effective May 1, 2026. Palmer brings over 25 years of leadership experience in healthcare services, benefits, and insurance, previously serving as CEO of Evernorth Health Services and CFO of Cigna. His appointment is expected to bolster AMN's governance and support its long-term growth strategy.
Can AMN Healthcare Services Outrun CVS Health in the Next Rally?
This article analyzes whether AMN Healthcare Services (AMN) is a better investment than CVS Health (CVS) following a recent surge in CVS stock. It compares both companies on revenue growth, profitability, and valuation multiples, concluding that AMN offers superior fundamentals in several key areas. Despite this, the article also emphasizes the inherent risks in stock investment and suggests a portfolio approach for mitigating individual stock volatility.
AMN Healthcare Services Q1 Earnings Call Highlights
AMN Healthcare Services reported Q1 2026 revenue significantly above guidance, driven by substantial labor disruption activity which contributed $722 million to its $1.38 billion total revenue. The Nurse and Allied Solutions segment saw its second-highest quarterly revenue, with stabilization and renewed growth noted in core businesses. Despite declines in Physician and Leadership Solutions and Technology segments due to cost management and pricing pressures, the company maintained a strong balance sheet and provided a Q2 outlook.
AMN Healthcare Services Q1 earnings call highlights
This article focuses on the key takeaways from AMN Healthcare Services' Q1 earnings call. It highlights the company's financial performance, operational achievements, and future outlook as discussed by management during the call.
AMN Healthcare Services (AMN) Is Up 9.7% After Mixed Q1 Beat, Soft Q2 Outlook And Governance Votes
AMN Healthcare Services (AMN) reported mixed first-quarter results with strong profitability but issued a cautious second-quarter outlook, forecasting near-break-even operations. Shareholders also rejected a proposal for an independent board chair amidst ongoing governance debates. The company's future performance hinges on balancing long-term demand for flexible healthcare staffing against short-term margin pressures and industry shifts.
AMN Healthcare Services (AMN) Is Up 9.7% After Mixed Q1 Beat, Soft Q2 Outlook And Governance Votes
AMN Healthcare Services reported mixed first-quarter results with strong sales and net income, but issued a soft second-quarter outlook with low operating margins. Shareholders rejected a proposal for an independent board chair, and the company filed for a new employee stock offering. The investment narrative focuses on long-term demand for healthcare staffing against near-term margin pressures and governance concerns.
AMN Healthcare Services Q1 Earnings Call Highlights
AMN Healthcare Services reported robust first-quarter 2026 revenue, significantly exceeding guidance, primarily due to substantial labor disruption activity. The company's President and CEO, Cary Grace, highlighted that five such events, three of which were large, contributed significantly to the $1.38 billion revenue. While Nurse and Allied Solutions thrived, segments like Physician and Leadership Solutions, and Technology and Workforce Solutions, faced declines due to cost management and pricing pressures respectively.
AMN Healthcare Services Q1 Earnings Call Highlights
AMN Healthcare Services reported robust first-quarter 2026 revenue, significantly exceeding guidance, primarily due to unusually high labor disruption activity. The company achieved $1.38 billion in revenue, with strong performance in its Nurse and Allied Solutions segment driven by rapid response volume and technology investments, including AI recruitment tools. Despite declines in Physician and Leadership Solutions, AMN management highlighted stabilization and renewed growth signs in several core businesses and provided a positive outlook for the second quarter, expecting adjusted EBITDA to grow at twice the rate of revenue long-term.
AMN Healthcare Services (AMN) TTM Loss And Margin Strain Challenge Bullish Recovery Narrative
AMN Healthcare Services (AMN) reported Q4 FY 2025 revenue of US$748.2 million and a basic EPS loss of US$0.20, with a trailing twelve-month loss of US$95.7 million. While revenue has fluctuated, recent losses challenge a bullish recovery narrative, despite a low P/S ratio and a DCF fair value significantly above the current share price. The company's profitability remains uncertain, with its valuation relying on future margin improvement.
AMN Healthcare Maintains Buy Rating -- Price Target Raised to $2
Truist Securities has maintained a "Buy" rating for AMN Healthcare Services (AMN) and raised its price target to $26.00. GuruFocus identifies AMN as 35.4% undervalued with a GF Value™ of $42.35 and a GF Score™ of 69/100, indicating solid investment potential despite moderate growth prospects. No insider trading activity has been reported recently.
Earnings call transcript: AMN Healthcare Q1 2026 earnings beat expectations
AMN Healthcare Services Inc. reported impressive Q1 2026 results, exceeding EPS forecasts by 29.63% with $2.10 and revenue expectations by 12.2% with $1.38 billion. The company effectively managed labor disruptions and saw significant growth in its Nurse and Allied Solutions segment, contributing to a 7.06% stock price increase in aftermarket trading. AMN Healthcare is confident in its strategic initiatives and technology-enabled solutions to drive sustainable long-term revenue and EBITDA growth.
AMN Healthcare (AMN) Q1 2026 profit surges on $722M labor disruption revenue
AMN Healthcare reported a significant turnaround in Q1 2026, with revenue doubling to $1,378.4 million and net income reaching $62.2 million, a reversal from a loss in the prior year. This strong performance was primarily driven by nurse and allied solutions revenue, which surged to $1,127.3 million due to substantial labor disruption events generating $722 million. While the overall gross margin narrowed slightly to 26.8%, operational cash flow increased sharply to $562.5 million, allowing for the full repayment of its revolving credit facility.
Earnings Flash (AMN) AMN Healthcare Services, Inc. Posts Q1 Adjusted EPS $2.10 per Share, vs. FactSet Est of $1.62
AMN Healthcare Services, Inc. (AMN) announced its first-quarter adjusted EPS of $2.10 per share, significantly surpassing FactSet's estimated $1.62. The company also reported Q1 revenue of $1.38 billion, exceeding FactSet's estimate of $1.23 billion. For Q2, AMN Healthcare expects revenue to be in the range of $620.0 million to $635.0 million.
Revenue doubles at AMN (NYSE: AMN) on disruptions as Q2 2026 guidance cools
AMN Healthcare reported a strong Q1 2026 with revenue doubling to $1.378 billion, significantly driven by $722 million from labor disruption events. While net income and adjusted diluted EPS saw substantial increases, the company's Q2 2026 guidance suggests a cooling period with much lower revenue expectations, indicating a high reliance on non-recurring disruption events for its Q1 performance. AMN Healthcare maintains a strong cash position and manageable debt despite the anticipated step-down in the next quarter.
AMN Healthcare Announces First Quarter 2026 Results
AMN Healthcare Services, Inc. reported strong first-quarter 2026 financial results, exceeding guidance with quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million. The company achieved GAAP diluted EPS of $1.59 and adjusted diluted EPS of $2.10, showing significant year-over-year growth. This performance was driven by increased travel nursing volume, allied health, international nurse staffing, and search businesses, along with substantial revenue from labor disruption events.
GUIDANCE: (AMN) AMN Healthcare Services, Inc. Expects Q2 Revenue Range $620.0M - $635.0M
AMN Healthcare Services, Inc. (AMN) has provided its revenue guidance for the second quarter, anticipating it to fall within the range of $620.0 million to $635.0 million. This financial outlook offers investors and stakeholders insight into the company's expected performance for the upcoming quarter.
AMN Healthcare: Q1 Earnings Snapshot
AMN Healthcare Services Inc. reported a significant turnaround in its first-quarter earnings, achieving a net income of $62.2 million after a loss in the previous year. The company's adjusted earnings per share of $2.10 surpassed Wall Street expectations, and its revenue reached $1.38 billion. AMN Healthcare's stock has performed well, rising 43% since the beginning of the year and 15% in the last 12 months.
(AMN) AMN Healthcare Services, Inc. Expects Q2 Revenue Range $620.0M - $635.0M
AMN Healthcare Services, Inc. reported its first-quarter earnings, with adjusted EPS of $2.10 and revenue of $1.38 billion, both exceeding FactSet estimates. The company anticipates its second-quarter revenue to fall between $620.0 million and $635.0 million. This financial outlook follows recent news including shareholder proposals and analyst rating adjustments for the firm.
Here's why AMN Healthcare Services (AMN) is a strong value stock
This article identifies AMN Healthcare Services (AMN) as a strong value stock. It likely details the reasons behind this assessment, potentially including financial metrics, market position, or future growth prospects.
AMN Healthcare Services (AMN) Q1 2026 Preview: EPS Est. $1.62, Reports May 7
AMN Healthcare Services (NYSE:AMN) is expected to report a dramatic earnings acceleration for Q1 2026, with Wall Street analysts forecasting $1.62 EPS on revenue of $1.23 billion. This represents a significant year-over-year surge, indicating a potential turnaround in the healthcare staffing market. Investors will closely monitor segment-level revenue, gross margin, and management's guidance for future quarters to assess the sustainability of this recovery.
Earnings To Watch: AMN Healthcare Services (AMN) Reports Q1 Results Tomorrow
AMN Healthcare Services (NYSE:AMN) will report its Q1 earnings tomorrow, Thursday, after market hours. The healthcare staffing company is expected to see a significant 78.8% year-on-year revenue growth, a reversal from the previous year's decline. Despite a past miss on EPS estimates, analyst sentiment remains positive, with shared prices in the healthcare providers & services segment showing a 6.5% increase and AMN's stock up 14.6% in the last month.
Director at AMN Healthcare (NYSE: AMN) granted 8,304 RSUs
AMN Healthcare Services director James H. Hinton received an equity award of 8,304 restricted stock units (RSUs) under the AMN Healthcare 2025 Equity Plan. These RSUs, granted on May 1, 2026, will vest on the earlier of one year from the grant date or the company’s 2027 Annual Meeting of Shareholders. Hinton has irrevocably elected to settle the vested RSUs in shares upon his separation from service as a director.
AMN Healthcare (AMN) director gains 43,063 shares as long-term RSUs vest
AMN Healthcare director Jeffrey R. Harris acquired 43,063 common shares through the vesting and settlement of Restricted Stock Units (RSUs) on May 1, 2026. These RSUs were granted under AMN equity plans, including awards from 2006–2010 and a 2025 grant, and their settlement coincided with the director's separation from service. Following these transactions, Harris directly holds 67,262 shares of AMN common stock.
AMN Healthcare (AMN) director adds 8,325 shares and receives 8,304 RSUs
AMN Healthcare director Sylvia Trent-Adams reported equity compensation changes, including the acquisition of 8,325 common shares from vested Restricted Stock Units (RSUs) and a new grant of 8,304 RSUs. These transactions are part of her compensation and are not open-market trades. Following these activities, Trent-Adams directly holds 16,797 shares of AMN common stock.
AMN (AMN) director Teri Fontenot awarded 8,304 restricted stock units
AMN Healthcare Services director Teri G. Fontenot was granted 8,304 Restricted Stock Units (RSUs) as equity compensation, as disclosed in a recent Form 4 filing. These RSUs, which represent a right to one share of AMN common stock each, were granted on May 1, 2026, and will vest on the earlier of one year from the grant date or the 2027 Annual Meeting of Shareholders. The RSUs will settle upon her separation from service, based on a prior election.
AMN Healthcare (NYSE: AMN) director receives 8,304 RSU equity award
AMN Healthcare director Celia P. Huber was granted 8,304 restricted stock units (RSUs) as equity compensation under the AMN Healthcare 2025 Equity Plan. These RSUs, each representing one share of common stock, will vest on the earlier of one year from the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders. This award aims to align her interests with long-term shareholder value.
AMN Healthcare (NYSE: AMN) director adds shares through RSU vesting and new grant
AMN Healthcare director Jorge A. Caballero increased his holdings through the exercise of 8,325 Restricted Stock Units (RSUs) and received a new grant of 8,304 RSUs. Following these compensation-related equity activities, Mr. Caballero directly holds 15,462 shares of AMN common stock. The transactions were reported in a Form 4 filing and did not involve any share sales.
Director at AMN Healthcare (AMN) granted 8,304 RSUs as equity award
AMN Healthcare director Eric P. Palmer was granted 8,304 Restricted Stock Units (RSUs) as an equity award on May 1, 2026, under the company's 2025 Equity Plan. These RSUs represent a contingent right to receive one share of AMN common stock each upon vesting, which is set for the earlier of the one-year anniversary of the grant date or AMN's 2027 Annual Meeting of Shareholders. Following this transaction, Palmer directly holds a total of 8,304 RSUs.
AMN Healthcare (NYSE: AMN) director adds shares via RSU vesting and new grant
AMN Healthcare Services director Mark G. Foletta reported acquiring 8,325 shares of Common Stock through the vesting and exercise of Restricted Stock Units (RSUs) and received a new grant of 8,304 RSUs. These transactions increased his direct Common Stock holdings to 21,598 shares. The newly granted RSUs will vest on the earlier of one year after the grant date (May 1, 2026) or the company’s 2027 Annual Meeting of Shareholders.
AMN Healthcare Services, Inc. Shareholders Approve Amendment No. 1 to 2025 Equity Plan at Annual Meeting
AMN Healthcare Services, Inc. shareholders approved Amendment No. 1 to the company's 2025 Equity Plan at their Annual Meeting on May 1, 2026. This amendment increases the total number of shares authorized for awards to 2,258,714, adding 1,420,000 shares to the plan. While this move aims to incentivize key talent, it also introduces the potential for share dilution, which shareholders and potential investors should monitor closely.
AMN Healthcare Shareholders Approve Equity Plan and Directors
At its annual meeting on May 1, 2026, AMN Healthcare Services shareholders approved an amendment to the company's 2025 Equity Plan and ratified KPMG LLP as the independent auditor for 2026. All nominated directors were re-elected, and executive compensation received approval, while a proposal for an independent board chairman was rejected. TipRanks' AI Analyst, Spark, rates AMN as Neutral, citing resilient cash generation and improved leverage, despite current profitability setbacks and weak technicals.
Shareholders back AMN Healthcare (NYSE: AMN) equity plan changes and board
AMN Healthcare Services, Inc. reported that its shareholders approved Amendment No. 1 to the 2025 Equity Plan and elected all nine director nominees at the Annual Meeting held on May 1, 2026. Shareholders voted on five proposals in total, with detailed tallies of "for," "against," "abstain," and "broker non-votes" disclosed, reflecting broad support for the board and the equity plan changes. One proposal, "Independent Board Chairman," was not approved due to significant opposition.
AMN Healthcare Services AGM: Directors Elected, Equity Plan Approved, Independent Chair Proposal Fails
AMN Healthcare Services (NYSE: AMN) held its 2026 annual meeting where all nine director nominees were elected, and an amendment to the 2025 Equity Plan was approved. A shareholder proposal advocating for an independent board chair failed, leaving the current chair/CEO structure intact. Management also noted signs of stabilization in the travel nurse business and highlighted expansions in their technology offerings like WorkWise and the Passport clinician app.
AMN Healthcare Services AGM: Directors Elected, Equity Plan Approved, Independent Chair Proposal Fails
AMN Healthcare Services held its 2026 annual meeting where all nine director nominees were elected, an equity plan was approved, and the advisory vote on executive compensation passed. A shareholder proposal advocating for an independent board chair failed. The company also reported signs of stabilization in its travel nurse business and expansion of its technology offerings like WorkWise and the Passport clinician app.
AMN Healthcare Services Inc (NYSE:AMN) Given Average Rating of "Hold" by Analysts
AMN Healthcare Services Inc (NYSE:AMN) has received a consensus "Hold" rating from nine brokerages, with an average 1-year price target of $22.64. The company recently reported Q4 revenue of $748.23 million and EPS of $0.22, meeting estimates despite a negative net margin. Institutional investors hold approximately 99.23% of the stock, with significant stake increases from firms like Boston Partners and Millennium Management.
Vanguard Capital Management (AMN) reports 1.96M shares, 5.07% stake
Vanguard Capital Management has reported a 5.07% stake in AMN Healthcare Services Inc., totaling 1,960,648 shares beneficially owned as of March 31, 2026. This disclosure was made via a Schedule 13G filing, indicating a passive investment. Vanguard holds sole dispositive power over all these shares and sole voting power for 283,222 shares, reflecting holdings managed across various Vanguard funds and accounts.
Pick These 5 Bargain Stocks With Exciting EV-to-EBITDA Ratios
This article highlights the EV-to-EBITDA ratio as a superior valuation metric compared to the traditional P/E ratio, especially for identifying undervalued companies or acquisition targets. It explains why EV-to-EBITDA provides a more comprehensive view of a company's total value and profitability by including debt and non-cash expenses. The article then identifies five bargain stocks—First American Financial (FAF), AMN Healthcare Services (AMN), Cenovus Energy (CVE), PG&E (PCG), and Safehold (SAFE)—that meet specific screening criteria based on EV-to-EBITDA and other financial metrics.
